MedTrace Logo

Sleep Deprivation Study

NCT05560620 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2022-09-29

No results posted yet for this study

Summary

The purpose of this study is to evaluate the measures of brain function, both neurophysiological (event-related potentials (ERPs) and functional (cognitive assessments), in response to sleep deprivation.

Conditions

  • Cognitive Change
  • Sleep Deprivation
  • Caffeine

Interventions

BEHAVIORAL

Sleep Deprivation

Participants will be randomized into either the sleep deprivation group or the control group, who will sleep regularly.

OTHER

Caffeine

On Day 2 morning, after the sleep deprivation or sleeping, participants will be randomized into receiving caffeinated or de-caffeinated coffee, which they will be blinded to.

OTHER

No Caffeine

De-caffeinated coffee

Sponsors & Collaborators

  • NeuroCatch Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-03
Primary Completion
2022-07-26
Completion
2022-08-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05560620 on ClinicalTrials.gov